Corebridge Q3 10-Q: $1.4B Net Income, But AOCI Loss Deepens to $15.2B on Rate-Driven Bond Losses
CRBG sits 61% above its 52-week low of $22.19.
Summary
Corebridge's Q3 10-Q confirms $1.4 billion of net income ($3.22 per diluted share) but shows AOCI deepening to a $15.2 billion loss as rising rates hit the bond portfolio, while buybacks and the pending Equitable merger proceed.
Key Events · Earnings and Guidance · CRBG
-
Q3 Net Income $1.4 Billion
Net income available to common shareholders was $1,440 million, or $3.22 per diluted share, versus $144 million ($0.27) a year earlier; nine-month net income was $1,371 million versus a $(1,180) million loss.
-
AOCI Loss Widens to $15.2 Billion
Accumulated other comprehensive loss grew to $15,244 million from $9,452 million at year-end, driven by a $10,063 million nine-month unrealized depreciation on fixed maturities as interest rates rose; total shareholders' equity fell to $6,729 million from $13,201 million.
-
Adjusted Book Value Rises to $41.37
Excluding AOCI and Fortitude Re funds-withheld marks, adjusted book value per common share rose to $41.37 from $39.83 at year-end, against a GAAP book value of $14.16.
-
Buybacks Continue at Pace
Corebridge repurchased 57,473,155 shares for $1,735 million in the first nine months, leaving $857 million of authorization at September 30; roughly 2 million more shares were bought for about $64 million through October 30, 2026.
Analysis · CRBG · Finance
The headline numbers were already out via yesterday's 8-K, but the full 10-Q shows the balance-sheet cost of the quarter: book equity fell to $6.7 billion from $13.2 billion at year-end as higher rates drove a $10.1 billion nine-month unrealized loss on the bond portfolio into AOCI. That accounting hit does not touch regulatory capital or cash flow the way GAAP equity suggests, and management's adjusted book value per share actually rose to $41.37 from $39.83 — the gap between the two is the whole story. Meanwhile the company kept buying back stock aggressively (57.5 million shares for $1.7 billion in nine months) even as it funds a $750 million note deal ahead of the pending all-stock merger with Equitable, which both shareholder bases approved July 30 and which is targeted to close by year-end 2026.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CRBG was trading at $35.74 on NYSE in the Finance sector, with a market capitalization of approximately $15.9B. The 52-week trading range was $22.19 to $36.56. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.